Athersys to Host Second Quarter 2014 Financial Results Call
July 16 2014 - 9:30AM
Athersys, Inc. (Nasdaq:ATHX) will release its second quarter 2014
financial results at approximately 4:00 PM (Eastern Time) on
Monday, August 11, 2014, and host a conference call shortly
thereafter at 4:30 PM (Eastern Time) to review the results. Gil Van
Bokkelen, Chairman and Chief Executive Officer, and William (B.J.)
Lehmann, President and Chief Operating Officer, will host the call
as follows:
|
|
Date |
August 11, 2014 |
Time |
4:30 p.m. (Eastern Time) |
Telephone access: US and Canada |
800-273-1254 |
Telephone access: International |
973-638-3440 |
Access code |
74126643 |
Live webcast |
www.athersys.com, under the Investors
section |
A replay will be available for on-demand listening shortly after
the completion of the call until 11:59 PM (Eastern Time) on August
25, 2014 at the aforementioned URL, or by dialing 800-585-8367 or
855-859-2056 in the U.S. and Canada, or from abroad 404-537-3406,
and entering access code 74126643.
About Athersys
Athersys is a clinical stage biotechnology company engaged in
the discovery and development of therapeutic product candidates
designed to extend and enhance the quality of human life. The
Company is developing its MultiStem® cell therapy product, a
patented, adult-derived "off-the-shelf" stem cell product platform
for disease indications in the cardiovascular, neurological,
inflammatory and immune disease areas. The Company currently has
several clinical stage programs involving MultiStem, including for
treating inflammatory bowel disease, ischemic stroke, damage caused
by myocardial infarction, and for the prevention of
graft-versus-host disease. Athersys has also developed a diverse
portfolio that includes other technologies and product development
opportunities, and has forged strategic partnerships and
collaborations with leading pharmaceutical and biotechnology
companies, as well as world-renowned research institutions in the
United States and Europe to further develop its platform and
products. More information is available at www.athersys.com.
CONTACT: William (B.J.) Lehmann, J.D.
President and Chief Operating Officer
Tel: (216) 431-9900
bjlehmann@athersys.com
Investor Relations:
Lisa M. Wilson
In-Site Communications
Tel: (917) 543-9932
lwilson@insitecony.com
Athersys (NASDAQ:ATHX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Athersys (NASDAQ:ATHX)
Historical Stock Chart
From Apr 2023 to Apr 2024